Transcription Factor Decoys

Transcription factor oligodeoxynucleotide (ODN) decoys are new research tools designed to enhance the study of gene regulation. The approach involves flooding the cells with enough double-stranded decoy to compete for binding of transcription factors with their consensus sequences in target genes. If present in high-enough concentrations, these "decoys" can negate the ability of the transcription factor to regulate gene expression. The technology has proven effective in vitro and more recently,

Written byAnita Flanagan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Auckland, New Zealand-based GeneDetect.com has designed ODN decoys to more than 45 common transcription factors, with plans to release more. Each decoy is a double-stranded, synthetic phosphorothioate deoxynucleotide, from 20 to 28 base pairs in length. "The flanking regions are proprietary," explains Paul Hughes, the company's CEO, "but the standard consensus regions are from transcription factor databases available on the Internet."

These decoys offer several benefits. First, they can be used in real time, in living cells. "Although you can add naked decoys to the cells, we suggest mixing the decoy with a liposome complex before adding it to the cells," says Hughes. The company recommends Carlsbad, Calif.-based Invitrogen Corp.'s OligofectAMINE reagent for this purpose. Since cell types vary in their susceptibility to transfection and different liposome complexes perform better than others do, "you may need to tweak the different conditions to get the best results," adds Hughes. The suggested ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies